A detailed history of Barclays PLC transactions in Liva Nova PLC stock. As of the latest transaction made, Barclays PLC holds 393,418 shares of LIVN stock, worth $18.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
393,418
Previous 393,418 -0.0%
Holding current value
$18.4 Million
Previous $20.7 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$43.38 - $54.59 $17.7 Million - $22.3 Million
-407,984 Reduced 50.91%
393,418 $20.7 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $28.8 Million - $35.7 Million
-555,794 Reduced 40.95%
801,402 $43.9 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $18.9 Million - $22.2 Million
388,405 Added 40.09%
1,357,196 $75.9 Million
Q4 2023

Feb 15, 2024

BUY
$43.45 - $53.66 $5.08 Million - $6.27 Million
116,921 Added 13.73%
968,791 $50.1 Million
Q3 2023

Nov 07, 2023

BUY
$50.12 - $58.87 $5.86 Million - $6.88 Million
116,842 Added 15.9%
851,870 $45 Million
Q2 2023

Aug 03, 2023

BUY
$42.28 - $51.43 $2.88 Million - $3.5 Million
68,100 Added 10.21%
735,028 $37.8 Million
Q1 2023

May 04, 2023

BUY
$40.84 - $58.14 $8.79 Million - $12.5 Million
215,304 Added 47.67%
666,928 $29.1 Million
Q4 2022

Feb 13, 2023

SELL
$43.88 - $56.16 $11.1 Million - $14.3 Million
-253,948 Reduced 35.99%
451,624 $25.1 Million
Q3 2022

Nov 03, 2022

BUY
$48.37 - $66.5 $8.9 Million - $12.2 Million
184,009 Added 35.28%
705,572 $35.8 Million
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $3.71 Million - $5.61 Million
64,800 Added 14.19%
521,563 $32.6 Million
Q1 2022

May 16, 2022

SELL
$71.02 - $86.99 $511,130 - $626,067
-7,197 Reduced 1.55%
456,763 $37.4 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $2.44 Million - $2.95 Million
31,857 Added 7.37%
463,960 $40.6 Million
Q3 2021

Nov 09, 2021

SELL
$76.02 - $88.62 $1.23 Million - $1.44 Million
-16,228 Reduced 3.62%
432,103 $34.2 Million
Q2 2021

Aug 13, 2021

SELL
$73.44 - $87.01 $2.38 Million - $2.82 Million
-32,443 Reduced 6.75%
448,331 $37.7 Million
Q1 2021

May 13, 2021

SELL
$62.9 - $82.41 $261,915 - $343,155
-4,164 Reduced 0.86%
480,774 $35.4 Million
Q4 2020

Feb 11, 2021

SELL
$46.01 - $68.74 $1.35 Million - $2.01 Million
-29,268 Reduced 5.69%
484,938 $32.1 Million
Q3 2020

Nov 12, 2020

SELL
$41.91 - $57.81 $28 Million - $38.6 Million
-668,388 Reduced 56.52%
514,206 $23.2 Million
Q2 2020

Aug 12, 2020

BUY
$39.87 - $56.9 $45.5 Million - $64.9 Million
1,140,317 Added 2697.25%
1,182,594 $56.9 Million
Q1 2020

May 13, 2020

SELL
$34.22 - $76.49 $588,960 - $1.32 Million
-17,211 Reduced 28.93%
42,277 $1.91 Million
Q4 2019

Feb 10, 2020

BUY
$68.92 - $85.27 $1.98 Million - $2.45 Million
28,690 Added 93.16%
59,488 $4.49 Million
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $798,394 - $960,989
-11,129 Reduced 26.54%
30,798 $2.27 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $1.24 Million - $1.81 Million
18,635 Added 80.01%
41,927 $3.02 Million
Q1 2019

May 15, 2019

BUY
$86.15 - $100.49 $1.21 Million - $1.41 Million
14,045 Added 151.89%
23,292 $2.27 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $2.86 Million - $4.26 Million
-33,939 Reduced 78.59%
9,247 $845,000
Q3 2018

Nov 14, 2018

SELL
$101.02 - $130.95 $4.91 Million - $6.36 Million
-48,587 Reduced 52.94%
43,186 $5.36 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $2.61 Million - $3.37 Million
31,944 Added 53.39%
91,773 $9.16 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $1.7 Million - $1.91 Million
21,232 Added 55.01%
59,829 $5.3 Million
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $171,243 - $210,380
-2,385 Reduced 5.82%
38,597 $3.08 Million
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $2.47 Million - $2.87 Million
40,982
40,982 $2.87 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.